155 related articles for article (PubMed ID: 30704844)
1. Case series of allergic bronchopulmonary aspergillosis treated successfully and safely with long-term mepolizumab.
Soeda S; To M; Kono Y; Yamawaki S; Tsuzuki R; Katsube O; Watanabe N; To Y
Allergol Int; 2019 Jul; 68(3):377-379. PubMed ID: 30704844
[No Abstract] [Full Text] [Related]
2. Combination omalizumab and mepolizumab therapy for refractory allergic bronchopulmonary aspergillosis.
Altman MC; Lenington J; Bronson S; Ayars AG
J Allergy Clin Immunol Pract; 2017; 5(4):1137-1139. PubMed ID: 28279664
[No Abstract] [Full Text] [Related]
3. Unexpected decrease in total IgE in a patient with allergic bronchopulmonary aspergillosis treated with omalizumab.
Wolf BL; Johnson A
J Allergy Clin Immunol Pract; 2014; 2(1):111-3. PubMed ID: 24565782
[No Abstract] [Full Text] [Related]
4. A case of allergic bronchopulmonary aspergillosis treated with omalizumab.
Sastre I; Blanco J; Mata H; García F
J Investig Allergol Clin Immunol; 2012; 22(2):145-7. PubMed ID: 22533243
[No Abstract] [Full Text] [Related]
5. Successful Treatment of Allergic Bronchopulmonary Aspergillosis With Benralizumab in a Patient Who Did Not Respond to Omalizumab.
Bernal-Rubio L; de-la-Hoz Caballer B; Almonacid-Sánchez C; González-de-Olano D
J Investig Allergol Clin Immunol; 2020; 30(5):378-379. PubMed ID: 32376515
[No Abstract] [Full Text] [Related]
6. Clinical efficacy and immunologic effects of omalizumab in allergic bronchopulmonary aspergillosis.
Voskamp AL; Gillman A; Symons K; Sandrini A; Rolland JM; O'Hehir RE; Douglass JA
J Allergy Clin Immunol Pract; 2015; 3(2):192-9. PubMed ID: 25640470
[TBL] [Abstract][Full Text] [Related]
7. A case of allergic bronchopulmonary aspergillosis successfully treated with mepolizumab.
Terashima T; Shinozaki T; Iwami E; Nakajima T; Matsuzaki T
BMC Pulm Med; 2018 Mar; 18(1):53. PubMed ID: 29587693
[TBL] [Abstract][Full Text] [Related]
8. Anti IgE antibody as treatment of allergic bronchopulmonary aspergillosis in a patient with cystic fibrosis.
Zicari AM; Celani C; De Castro G; Valerio De Biase R; Duse M
Eur Rev Med Pharmacol Sci; 2014 Jul; 18(13):1839-41. PubMed ID: 25010610
[TBL] [Abstract][Full Text] [Related]
9. Allergic bronchopulmonary aspergillosis in asthma.
Knutsen AP
Expert Rev Clin Immunol; 2017 Jan; 13(1):11-14. PubMed ID: 27599560
[No Abstract] [Full Text] [Related]
10. Fungal Allergens in a Saxophonist Who Had Never Smoked With Allergic Bronchopulmonary Aspergillosis Previously Diagnosed as COPD.
Moreno-Ancillo A; Gil-Adrados AC; Pineda F; Jurado-Palomo J; Gutiérrez-Fernández D; Moreno-Gil R
J Investig Allergol Clin Immunol; 2016; 26(6):386-388. PubMed ID: 27996950
[No Abstract] [Full Text] [Related]
11. Omalizumab therapy for allergic bronchopulmonary aspergillosis in children with cystic fibrosis: a synthesis of published evidence.
Tanou K; Zintzaras E; Kaditis AG
Pediatr Pulmonol; 2014 May; 49(5):503-7. PubMed ID: 24167019
[TBL] [Abstract][Full Text] [Related]
12. Purification of a major allergen, Asp f 2 binding to IgE in allergic bronchopulmonary aspergillosis, from culture filtrate of Aspergillus fumigatus.
Banerjee B; Kurup VP; Greenberger PA; Hoffman DR; Nair DS; Fink JN
J Allergy Clin Immunol; 1997 Jun; 99(6 Pt 1):821-7. PubMed ID: 9215251
[TBL] [Abstract][Full Text] [Related]
13. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
Jat KR; Walia DK; Khairwa A
Cochrane Database Syst Rev; 2013 Sep; (9):CD010288. PubMed ID: 24043500
[TBL] [Abstract][Full Text] [Related]
14. IgE antibody to Aspergillus fumigatus recombinant allergens in cystic fibrosis patients with allergic bronchopulmonary aspergillosis.
Knutsen AP; Hutcheson PS; Slavin RG; Kurup VP
Allergy; 2004 Feb; 59(2):198-203. PubMed ID: 14763934
[TBL] [Abstract][Full Text] [Related]
15. Clinical-immunologic correlates: a differential diagnostic update. Allergic bronchopulmonary aspergillosis.
Chryssanthopoulos C; Fink JN
J Asthma; 1984; 21(1):41-51. PubMed ID: 6423615
[No Abstract] [Full Text] [Related]
16. [Relation of bronchial asthma and allergic bronchopulmonary aspergillosis].
Alekseev VG; Sinopal'nikov AI; Voroniva NA; Gerasinov GM
Klin Med (Mosk); 1989 Dec; 67(12):53-6. PubMed ID: 2697785
[TBL] [Abstract][Full Text] [Related]
17. Severe asthma concomitant with allergic bronchopulmonary aspergillosis successfully treated with mepolizumab.
Oda N; Miyahara N; Senoo S; Itano J; Taniguchi A; Morichika D; Fujii U; Maeda Y; Kiura K; Kanehiro A
Allergol Int; 2018 Oct; 67(4):521-523. PubMed ID: 29665990
[No Abstract] [Full Text] [Related]
18. Aspergillus fumigatus components distinguish IgE but not IgG4 profiles between fungal sensitization and allergic broncho-pulmonary aspergillosis.
Vitte J; Romain T; Carsin A; Gouitaa M; Stremler-Le Bel N; Baravalle-Einaudi M; Cleach I; Reynaud-Gaubert M; Dubus JC; Mège JL
Allergy; 2016 Nov; 71(11):1640-1643. PubMed ID: 27542151
[TBL] [Abstract][Full Text] [Related]
19. Omalizumab, an additional therapy for allergic bronchopulmonary aspergillosis.
Evans MO; Morris MJ; Coop CA; Evans SE
Ann Allergy Asthma Immunol; 2015 Sep; 115(3):250-1. PubMed ID: 26162570
[No Abstract] [Full Text] [Related]
20. Allergens of Aspergillus fumigatus: identification and characterization of components combining with specific IgE antibody.
Longbottom JL
Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Jul; 261(4):503-8. PubMed ID: 3532634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
